GIM
PACB icon

Granahan Investment Management’s Pacific Biosciences PACB Stock Holding History

Granahan Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-821,306
Closed -$8.06M – 194
2023
Q4 		$8.06M Buy
821,306
+123,680
+18% +$1.01M 0.27% 97
2023
Q3 		$5.83M Buy
697,626
+87,366
+14% +$998K 0.21% 121
2023
Q2 		$8.12M Sell
610,260
-155,867
-20% -$1.89M 0.25% 102
2023
Q1 		$8.87M Buy
766,127
+88,969
+13% +$885K 0.27% 96
2022
Q4 		$5.54M Buy
677,158
+102,969
+18% +$887K 0.17% 124
2022
Q3 		$3.33M Sell
574,189
-147,219
-20% -$845K 0.11% 145
2022
Q2 		$3.19M Buy
721,408
+309,225
+75% +$1.88M 0.11% 141
2022
Q1 		$3.75M Sell
412,183
-76,712
-16% -$883K 0.09% 147
2021
Q4 		$10M Buy
488,895
+36,593
+8% +$883K 0.21% 112
2021
Q3 		$11.6M Buy
452,302
+170,315
+60% +$5.05M 0.22% 104
2021
Q2 		$9.86M Buy
+281,987
New +$8.2M 0.18% 117

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Granahan Investment Management's PACB Position: Q1 2024 in Review

Granahan Investment Management sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 821,306 shares — an estimated $8.06M sold.

Granahan Investment Management first reported a position in PACB in Q2 2021 and held it in 11 quarters. The position peaked at $11.6M in Q3 2021. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • Granahan Investment Management reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • Granahan Investment Management sold 821,306 Pacific Biosciences shares in Q1 2024, an estimated $8.06M.
  • Granahan Investment Management first reported a position in Pacific Biosciences in Q2 2021 and held it in 11 quarters.
  • Granahan Investment Management's Pacific Biosciences position peaked at $11.6M in Q3 2021.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Granahan Investment Management's 13F filing for Q1 2024, filed 15 May 2024.